» Articles » PMID: 8198049

Efficacy of Water-soluble Vitamin E in the Treatment of Vitamin E Malabsorption in Short-bowel Syndrome

Overview
Journal Am J Clin Nutr
Publisher Elsevier
Date 1994 Jun 1
PMID 8198049
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

A water-soluble form of vitamin E, tocopheryl succinate polyethylene glycol 1000 (TPGS), was used as an oral vitamin E supplement in a 71-y-old patient with severe fat malabsorption and vitamin E deficiency secondary to short-bowel syndrome. An absorption test with deuterium-labeled TPGS demonstrated that TPGS was absorbed and the released alpha-tocopherol was transported normally in lipoproteins. The disappearance portion of the deuterated alpha-tocopherol curves were parallel to those in control subjects, suggesting normal metabolic turnover of alpha-tocopherol. Long-term (3 y) supplementation with orally administered TPGS (10,360 mg or 4000 IU/d) maintained normal plasma alpha-tocopherol concentrations, raised adipose tissue alpha-tocopherol concentrations, and prevented further progression of the neurological abnormalities resulting from vitamin E deficiency. Thus, TPGS can be an effective vitamin E supplement in short-bowel syndrome despite severe fat malabsorption.

Citing Articles

Evaluation of Anticancer Efficacy of D-α-Tocopheryl Polyethylene-Glycol Succinate and Soluplus Mixed Micelles Loaded with Olaparib and Rapamycin Against Ovarian Cancer.

Shin Y, Choi J, Yoon M, Yoo M, Shin D, Lee J Int J Nanomedicine. 2024; 19:7871-7893.

PMID: 39114180 PMC: 11304412. DOI: 10.2147/IJN.S468935.


Validation of Knock-Out Caco-2 TC7 Cells as Models of Enterocytes of Patients with Familial Genetic Hypobetalipoproteinemias.

Bordat C, Vairo D, Cuerq C, Halimi C, Peiretti F, Penhoat A Nutrients. 2023; 15(3).

PMID: 36771214 PMC: 9921550. DOI: 10.3390/nu15030505.


TPGS2000-DOX Prodrug Micelles for Improving Breast Cancer Therapy.

Tang L, Jiang W, Wu L, Yu X, He Z, Shan W Int J Nanomedicine. 2021; 16:7875-7890.

PMID: 34880613 PMC: 8647655. DOI: 10.2147/IJN.S335405.


Efficacy of two vitamin E formulations in patients with abetalipoproteinemia and chylomicron retention disease.

Cuerq C, Henin E, Restier L, Blond E, Drai J, Marcais C J Lipid Res. 2018; 59(9):1640-1648.

PMID: 30021760 PMC: 6121919. DOI: 10.1194/jlr.M085043.


Drug Delivery Innovations for Enhancing the Anticancer Potential of Vitamin E Isoforms and Their Derivatives.

Neophytou C, Constantinou A Biomed Res Int. 2015; 2015:584862.

PMID: 26137487 PMC: 4475563. DOI: 10.1155/2015/584862.